SYRS – Knox Daily

Analysts Viewpoint

In a filing, Syros Pharmaceuticals Inc revealed its Director Fanucci Marsha acquired Company’s shares for reported $924.0 on Mar 14

Insiders Updates

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Insiders Updates

Syros Pharmaceuticals Inc’s filing revealed that its Affiliate Flagship Pioneering Fund VII, acquired Company’s shares for reported $0.27 million on

Analysts Viewpoint

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Stock Earnings

In a filing, Syros Pharmaceuticals Inc revealed its Affiliate Flagship Pioneering Fund VII, acquired Company’s shares for reported $0.27 million

Analysts Viewpoint

Syros Pharmaceuticals Inc’s filing revealed that its Affiliate Flagship Pioneering Fund VII, acquired Company’s shares for reported $0.27 million on

Analysts Viewpoint

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Tag: SYRS